newsfilter
← Latest News
GlobeNewswire·

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences,